Jim Bialick
Jim Bialick is a known expert on health information technology policy, the regulation of emerging health technologies, and public health system design. He has a keen interest in the overall modernization of healthcare and works with stakeholders to develop new and innovative methods to personalize the care experience in a way that will lead to the sustainable improvement of health systems, make healthcare safer, and reduce costs.
Jim is currently the President of the Patient Safety Movement Foundation, which is singularly focused on the elimination of preventable patient death by 2020. The organization secures commitments from hospitals to implement actionable patient safety solutions and from health technology companies to openly share their data; these activities are on track to save over 6,000 lives in 2014.
Previous to joining the Patient Safety Movement Foundation Jim was the co-founder and former Executive Director of the Newborn Foundation and the Newborn Coalition, two action-based non-profit organizations focused on education and advocacy to improve maternal and child health domestically and internationally.
In his role with the Newborn Foundation Jim has secured international funding for two major population health screening programs and was a key architect in the world’s largest pulse oximetry screening pilot program, targeting congenital heart disease neonatal sepsis, and neonatal pneumonia; the program is currently under way across six provinces in China.
As Executive Director of the Newborn Coalition, Jim has played a leading role in the drafting, development, or passage of thirty-three state laws mandating newborn screening for congenital heart disease. In two years these advocacy efforts have increased the number of newborns screened in the United States by more than 4000%.
Jim has also played a key role in reforming public safety programs for the evaluation of healthcare related technologies. He has testified twice before the Energy & Commerce Committee of the US House of Representatives on the regulation of future technologies and remains a trusted advisor to several Members of Congress and Senators on healthcare issues.
Jim is also former Senior Vice President for Public Policy for Horizon Government Affairs in Washington, DC where he led health information technology and medical device policy development across five diverse coalitions representing over two hundred corporations and non-profit organizations.
Jim lives in Laguna Niguel, CA with his wife, daughter, and two dogs.
Mary Jo Carden
Director of Regulatory Affairs
AMCP
Before joining AMCP, Ms. Carden served as Director of Regulatory Affairs at Medco Health Solutions, Inc. and President and Founder of Carden & Associates, a boutique health care policy and advocacy firm founded in 2006. Prior to her consulting experience, she held positions for eight years with the American Society of Consultant Pharmacists (ASCP), including as Director of Government Affairs. She also has practiced community pharmacy.
She holds the position of Assistant Adjunct Professor at the University of Florida College of Pharmacy and was previously an Associate Adjunct Professor at Shenandoah University, Bernard J. Dunn School of Pharmacy.
Ms. Carden has specialized knowledge and expertise in health care policy and regulatory issues including the Medicare Part D and B programs and other public and private pharmacy reimbursement programs; medication therapy management programs; controlled substance issues; and health information technology and privacy.
She holds a Bachelor of Science in Pharmacy degree from University of Pittsburgh School of Pharmacy and a Juris Doctor degree from the Catholic University of America in Washington, D.C. She is admitted to the State Bar of Maryland and is licensed as a pharmacist in the Commonwealth of Virginia.